38 results on '"Diagnostic reagents industry -- Securities"'
Search Results
2. Investing in Undervalued Mid-Cap Stocks Amid Growing Rate Uncertainty
3. Quidel Announces Private Exchange Transactions
4. Moody's announces completion of a periodic review of ratings of Lantheus Medical Imaging, Inc
5. FORM 8-K: QUIDEL CORP|DE Files Current Report Updated on 01-06-18
6. Quidel Announces Private Exchange Transactions (Updated on 31 May 2018)
7. Quidel Announces Private Exchange Transactions
8. Profile of Julian Baines, Chief Executive Officer of EKF Diagnostics
9. Profile of Julian Baines, Chief Executive Officer of EKF Diagnostics
10. Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
11. Profile of George Migausky Executive Vice President and Chief Financial Officer of Dimension Therapeutics
12. Profile of George Migausky Executive Vice President of Dimension Therapeutics, Inc
13. Profile of Julian Baines Chief Executive Officer of EKF DIAGNOSTICS HOLDINGS PLC
14. Moody's expectations for Abbott's ratings unchanged following news of medical optics sale
15. Moody's: Lantheus' equity issuance is credit positive; ratings unaffected
16. Aide Says Stewart Sold Stock on Tip; Witness recounts what he said were efforts by his ex-boss, Stewart's stockbroker, to get him to adopt 'cover stories
17. Stewart Maintains Innocence at Trial; The defendants repeat pleas as the case begins
18. Stewart Case Poses Challenges for All Parties as Trial Begins Today
19. Alere Inc announces USD3.00 per preferred share dividend
20. Alere Inc reports USD3.00 per preferred share dividend
21. Judge Refuses to Dismiss Two Charges Against Martha Stewart: Obstruction-of-justice and securities fraud counts stand, the judge rules, paving the way for a January trial
22. A Pantry Full of Defense Strategies; Martha Stewart's case is winnable, experts say, citing an assortment of available trial gambits
23. Stewart Publicly Proclaims Innocence
24. IN BRIEF / COURTS; Waksal Is Accused of Cheating Investor
25. THE NATION; SEC Likely to Charge Martha Stewart; The staff recommends civil action in the ImClone insider trading case, a source says
26. Waksal Pleads Guilty to Six Charges; Prosecutors say the ImClone founder remains uncooperative in their widening probe, which includes Martha Stewart
27. THE NATION; A Recipe for Disaster for Martha Stewart's Empire
28. Waksal Indicted on More Charges; Courts: The grand jury action, which the former CEO of ImClone had sought to avoid, allows the case to go to trial
29. Wall St. Batters Martha Stewart Stock; Media: Reports of a wider probe rattle investors, but analysts say her company's business appears strong
30. IMCLONE INQUIRY; Insider Trading an Issue That Won't Go Away; Securities: It's not like the 1980s, but such cases are increasing after years of decline, experts say
31. ImClone Saga Shows Biotech Risk; Investments: Analysts question why Bristol-Myers didn't see problems in firm before acquiring 19.9% stake. Congressional probe may offer answers
32. Alere Inc announces USD3.00 per share dividend
33. Alere Inc announces USD3.00 per preferred share dividend
34. Neopharm nets $34 million in secondary stock offering
35. Judge says no retrial for Martha Stewart
36. Stewart asks judge to void her conviction: Attorneys seek a new trial because of alleged perjury by a key government witness
37. Martha Stewart hearing delayed: A judge postpones the sentencing to July 8, signaling that alleged perjury by a U.S. agent will be a serious issue
38. Witness lied in Martha Stewart trial, U.S. charges
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.